Literature DB >> 19730990

Novel missense mutation in FHIT gene: interpreting the effect in HPV-mediated cervical cancer in Indian women.

Md Kausar Neyaz1, Showket Hussain, Md Imtaiyaz Hassan, Bhudev C Das, Syed Akhtar Husain, Mausumi Bharadwaj.   

Abstract

Human papillomavirus (HPV) is considered to be a major etiological factor but is not sufficient for the development of cervical cancer. Other host factors including altered tumor suppressor gene activities might contribute to the carcinogenic process. Fragile Histidine Triad (FHIT) has been shown to play a pivotal role in carcinogenesis. Therefore, we made an attempt to find out point mutation of FHIT gene in HPV mediated cervical cancer in Indian women. 112 cases of cervical carcinoma tissue biopsies and 38 cervical scrapes samples of normal cytology were employed for this study. Herein, we report a novel mutation identified at nucleotide position 655, at codon 98 from CAT --> CGT with ultimate replacement of amino acid Histidine by Arginine in cervical cancer cases. Molecular modeling was performed to predict the effect of this mutation in disease pathology. We predict that this change, His to Arg substitution in substrate-binding domain may generate catalytically inactive protein with loss of tumor suppressor activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19730990     DOI: 10.1007/s11010-009-0240-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  35 in total

1.  Public health. HPV's peculiarities, from infection to disease.

Authors:  Jon Cohen
Journal:  Science       Date:  2005-04-29       Impact factor: 47.728

2.  FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites.

Authors:  C M Wilke; B K Hall; A Hoge; W Paradee; D I Smith; T W Glover
Journal:  Hum Mol Genet       Date:  1996-02       Impact factor: 6.150

3.  FHIT gene mutations and single nucleotide polymorphism in Indian oral and cervical squamous cell carcinomas.

Authors:  K Kannan; A K Munirajan; V Bhuvarahamurthy; B K Mohanprasad; P Shankar; N Tsuchida; G Shanmugam
Journal:  Oral Oncol       Date:  2000-03       Impact factor: 5.337

4.  FHIT alterations in cancerous and non-cancerous cervical epithelium.

Authors:  K Yoshino; T Enomoto; T Nakamura; H Sun; K Ozaki; R Nakashima; H Wada; J Saitoh; Y Watanabe; K Noda; Y Murata
Journal:  Int J Cancer       Date:  2000-01-01       Impact factor: 7.396

5.  Role of FHIT in human cancer.

Authors:  C M Croce; G Sozzi; K Huebner
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

6.  Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.

Authors:  D L Greenspan; D C Connolly; R Wu; R Y Lei; J T Vogelstein; Y T Kim; J E Mok; N Muñoz; F X Bosch; K Shah; K R Cho
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

Review 7.  Prospects and prejudices of human papillomavirus vaccines in India.

Authors:  Bhudev C Das; Showket Hussain; Vilas Nasare; Mausumi Bharadwaj
Journal:  Vaccine       Date:  2008-04-14       Impact factor: 3.641

8.  Effect of aberrant promoter methylation of FHIT and RASSF1A genes on susceptibility to cervical cancer in a North Indian population.

Authors:  M Kausar Neyaz; R Suresh Kumar; Showket Hussain; Samar H Naqvi; Indu Kohaar; Nisha Thakur; Veena Kashyap; Bhudev C Das; Syed Akhtar Husain; Mausumi Bharadwaj
Journal:  Biomarkers       Date:  2008-09       Impact factor: 2.658

9.  Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study.

Authors:  Silvia Franceschi; Thangarajan Rajkumar; Salvatore Vaccarella; Vendhan Gajalakshmi; Ajit Sharmila; Peter J F Snijders; Nubia Muñoz; Chris J L M Meijer; Rolando Herrero
Journal:  Int J Cancer       Date:  2003-10-20       Impact factor: 7.396

10.  Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase.

Authors:  L D Barnes; P N Garrison; Z Siprashvili; A Guranowski; A K Robinson; S W Ingram; C M Croce; M Ohta; K Huebner
Journal:  Biochemistry       Date:  1996-09-10       Impact factor: 3.162

View more
  5 in total

1.  Effect of FHIT loss and p53 mutation on HPV-infected lung carcinoma development.

Authors:  Yan Yu; Xiaofei Liu; Yuxuan Yang; Xiaodan Zhao; Jianjun Xue; Weixiao Zhang; Aimin Yang
Journal:  Oncol Lett       Date:  2015-05-15       Impact factor: 2.967

Review 2.  Epigenetics and cervical cancer: from pathogenesis to therapy.

Authors:  Jinchuan Fang; Hai Zhang; Sufang Jin
Journal:  Tumour Biol       Date:  2014-02-20

3.  Frustration analysis of TBK1 missense mutations reported in ALS/FTD and cancer patients.

Authors:  Fatima Khatoon; Vijay Kumar; Farah Anjum; Alaa Shafie; Mohd Adnan; Md Imtaiyaz Hassan
Journal:  3 Biotech       Date:  2022-07-14       Impact factor: 2.893

4.  Reduction in the copy number and expression level of the recurrent human papillomavirus integration gene fragile histidine triad (FHIT) predicts the transition of cervical lesions.

Authors:  Liming Wang; Hui Shen; Bei Feng; Da Zhu; Lan Yu; Xun Tian; Ci Ren; Chun Gao; Xiaomin Li; Ding Ma; Zheng Hu; Hui Wang
Journal:  PLoS One       Date:  2017-04-17       Impact factor: 3.240

5.  Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in Indian population.

Authors:  Rupal Sinha; Showket Hussain; Ravi Mehrotra; R Suresh Kumar; Kapil Kumar; Pankaj Pande; Dinesh Chandra Doval; Seemi Farhat Basir; Mausumi Bharadwaj
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.